![](https://webarchive.library.unt.edu/eot2008/20090514065740im_/http://www.cancer.gov/images/spacer.gif) |
|
(SOO-tent)
![](https://webarchive.library.unt.edu/eot2008/20090514065740im_/http://www.cancer.gov/images/spacer.gif)
| A
drug used to treat gastrointestinal stromal tumors (GIST)
that have not responded to treatment with imatinib mesylate
(Gleevec). Sutent is also
used to treat advanced kidney cancer and is being studied
in the treatment of other types of cancer. It is a type of
tyrosine kinase inhibitor, a type of vascular endothelial
growth factor (VEGF) receptor inhibitor, and a type of
angiogenesis inhibitor. Also called SU011248, SU11248, sunitinib, and sunitinib malate. |
Previous Definitions: | surgical oncologist, surveillance, survival rate, survivor, survivorship | Next Definitions: | SV40, sweet elm, SWS, sympathetic nervous system, symptom |
|
![](https://webarchive.library.unt.edu/eot2008/20090514065740im_/http://www.cancer.gov/images/spacer.gif) |